230 related articles for article (PubMed ID: 32339354)
1. Alternative splicing related genetic variants contribute to bladder cancer risk.
Guo Z; Zhu H; Xu W; Wang X; Liu H; Wu Y; Wang M; Chu H; Zhang Z
Mol Carcinog; 2020 Aug; 59(8):923-929. PubMed ID: 32339354
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in splicing factor genes and susceptibility to bladder cancer.
Wang X; Guo Z; Zhu H; Xin J; Yuan L; Qin C; Wang M; Zhang Z; Wang Y; Chu H
Gene; 2022 Jan; 809():146022. PubMed ID: 34673209
[TBL] [Abstract][Full Text] [Related]
3. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.
Tian J; Wang Z; Mei S; Yang N; Yang Y; Ke J; Zhu Y; Gong Y; Zou D; Peng X; Wang X; Wan H; Zhong R; Chang J; Gong J; Han L; Miao X
Nucleic Acids Res; 2019 Jan; 47(D1):D909-D916. PubMed ID: 30329095
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene.
Saferali A; Yun JH; Parker MM; Sakornsakolpat P; Chase RP; Lamb A; Hobbs BD; Boezen MH; Dai X; de Jong K; Beaty TH; Wei W; Zhou X; Silverman EK; Cho MH; Castaldi PJ; Hersh CP; ;
PLoS Genet; 2019 Jul; 15(7):e1008229. PubMed ID: 31269066
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of
He S; Cao R; Mao Y; Li N; Wang Y; Ma H; Tian K
J Gynecol Oncol; 2023 May; 34(3):e40. PubMed ID: 36731897
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.
Liu X; Qian D; Liu H; Abbruzzese JL; Luo S; Walsh KM; Wei Q
Mol Carcinog; 2020 Aug; 59(8):930-939. PubMed ID: 32367578
[TBL] [Abstract][Full Text] [Related]
7. LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1.
Liu H; Wang X; Guo Z; Sun G; Lv Q; Qin C; Yuan L; Wang Y; Du M; Wang M; Zhang Z; Chu H
Cancer Med; 2023 Jul; 12(13):14440-14451. PubMed ID: 37211917
[TBL] [Abstract][Full Text] [Related]
8. Integrative splicing-quantitative-trait-locus analysis reveals risk loci for non-small-cell lung cancer.
Wang Y; Ding Y; Liu S; Wang C; Zhang E; Chen C; Zhu M; Zhang J; Zhu C; Ji M; Dai J; Jin G; Hu Z; Shen H; Ma H
Am J Hum Genet; 2023 Sep; 110(9):1574-1589. PubMed ID: 37562399
[TBL] [Abstract][Full Text] [Related]
9. Functional variants of RPS6KB1 and PIK3R1 in the autophagy pathway genes and risk of bladder cancer.
Ma L; Zhang D; Huang Z; Zheng R; Du M; Lv Q; Qin C; Chu H; Yuan L; Zhang Z
Arch Toxicol; 2022 Jan; 96(1):367-375. PubMed ID: 34668023
[TBL] [Abstract][Full Text] [Related]
10. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk.
Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
[TBL] [Abstract][Full Text] [Related]
11. Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.
Liu H; Wang LE; Liu Z; Chen WV; Amos CI; Lee JE; ; ; Iles MM; Law MH; Barrett JH; Montgomery GW; Taylor JC; MacGregor S; Cust AE; Newton Bishop JA; Hayward NK; Bishop DT; Mann GJ; Affleck P; Wei Q
Carcinogenesis; 2013 Apr; 34(4):885-92. PubMed ID: 23291271
[TBL] [Abstract][Full Text] [Related]
12. Integrative genomic analysis of N6-methyladenosine-single nucleotide polymorphisms (m
Xuan Z; Zhang Y; Jiang J; Zheng X; Hu X; Yang X; Shao Y; Zhang G; Huang P
Bioengineered; 2021 Dec; 12(1):2389-2397. PubMed ID: 34151731
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous adipose tissue splice quantitative trait loci reveal differences in isoform usage associated with cardiometabolic traits.
Brotman SM; Raulerson CK; Vadlamudi S; Currin KW; Shen Q; Parsons VA; Iyengar AK; Roman TS; Furey TS; Kuusisto J; Collins FS; Boehnke M; Laakso M; Pajukanta P; Mohlke KL
Am J Hum Genet; 2022 Jan; 109(1):66-80. PubMed ID: 34995504
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.
Wang M; Li Z; Chu H; Lv Q; Ye D; Ding Q; Xu C; Guo J; Du M; Chen J; Song Z; Yin C; Qin C; Gu C; Zhu Y; Xia G; Liu F; Zhang Z; Yuan L; Fu G; Hu Z; Tong N; Shen J; Liu K; Sun J; Sun Y; Li J; Li X; Shen H; Xu J; Shi Y; Zhang Z
Cancer Res; 2016 Jun; 76(11):3277-84. PubMed ID: 27206850
[TBL] [Abstract][Full Text] [Related]
17. Splicing annotation of endometrial cancer GWAS risk loci reveals potentially causal variants and supports a role for
Canson DM; O'Mara TA; Spurdle AB; Glubb DM
HGG Adv; 2023 Apr; 4(2):100185. PubMed ID: 36908940
[TBL] [Abstract][Full Text] [Related]
18. Identification of common genetic variants controlling transcript isoform variation in human whole blood.
Zhang X; Joehanes R; Chen BH; Huan T; Ying S; Munson PJ; Johnson AD; Levy D; O'Donnell CJ
Nat Genet; 2015 Apr; 47(4):345-52. PubMed ID: 25685889
[TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
Hosen MB; Islam J; Salam MA; Islam MF; Hawlader MZ; Kabir Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):78-84. PubMed ID: 25376209
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
Zhang Y; Zhang L; Li R; Chang DW; Ye Y; Minna JD; Roth JA; Han B; Wu X
Ann Oncol; 2017 Jul; 28(7):1625-1630. PubMed ID: 28383694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
